Daolin Tang

Author PubWeight™ 68.78‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 2012 20.08
2 HMGB1 promotes drug resistance in osteosarcoma. Cancer Res 2011 2.82
3 RAGE (Receptor for Advanced Glycation Endproducts), RAGE ligands, and their role in cancer and inflammation. J Transl Med 2009 2.56
4 Autophagy inhibition in combination cancer treatment. Curr Opin Investig Drugs 2009 1.79
5 HMGB1 in cancer: good, bad, or both? Clin Cancer Res 2013 1.79
6 UV irradiation resistance-associated gene suppresses apoptosis by interfering with BAX activation. EMBO Rep 2011 1.68
7 Autophagy regulates myeloid cell differentiation by p62/SQSTM1-mediated degradation of PML-RARα oncoprotein. Autophagy 2011 1.47
8 p53/HMGB1 complexes regulate autophagy and apoptosis. Cancer Res 2012 1.41
9 HMGB1: a novel Beclin 1-binding protein active in autophagy. Autophagy 2010 1.30
10 The expression of the receptor for advanced glycation endproducts (RAGE) is permissive for early pancreatic neoplasia. Proc Natl Acad Sci U S A 2012 1.30
11 Targeting HMGB1-mediated autophagy as a novel therapeutic strategy for osteosarcoma. Autophagy 2012 1.19
12 Eat-me: autophagy, phagocytosis, and reactive oxygen species signaling. Antioxid Redox Signal 2012 1.11
13 DAMP-mediated autophagy contributes to drug resistance. Autophagy 2011 1.10
14 The inhibition of LPS-induced production of inflammatory cytokines by HSP70 involves inactivation of the NF-kappaB pathway but not the MAPK pathways. Shock 2006 1.10
15 HMGB1 as an autophagy sensor in oxidative stress. Autophagy 2011 1.08
16 Autophagy in pancreatic cancer pathogenesis and treatment. Am J Cancer Res 2012 1.07
17 PKR-dependent inflammatory signals. Sci Signal 2012 1.07
18 The Receptor for Advanced Glycation End-products (RAGE) protects pancreatic tumor cells against oxidative injury. Antioxid Redox Signal 2011 1.05
19 Tumor immunity times out: TIM-3 and HMGB1. Nat Immunol 2012 1.04
20 The receptor for advanced glycation end products promotes pancreatic carcinogenesis and accumulation of myeloid-derived suppressor cells. J Immunol 2012 1.03
21 DAMPs and autophagy: cellular adaptation to injury and unscheduled cell death. Autophagy 2013 1.02
22 Life after death: targeting high mobility group box 1 in emergent cancer therapies. Am J Cancer Res 2013 1.01
23 Posttranslational modification of autophagy-related proteins in macroautophagy. Autophagy 2015 1.01
24 Apoptosis to autophagy switch triggered by the MHC class III-encoded receptor for advanced glycation endproducts (RAGE). Autophagy 2011 0.99
25 HMGB1 regulates autophagy through increasing transcriptional activities of JNK and ERK in human myeloid leukemia cells. BMB Rep 2011 0.98
26 AGER/RAGE-mediated autophagy promotes pancreatic tumorigenesis and bioenergetics through the IL6-pSTAT3 pathway. Autophagy 2012 0.98
27 Functional analysis of a novel KRAB/C2H2 zinc finger protein Mipu1. Biochem Biophys Res Commun 2007 0.97
28 Induction of KLF4 in response to heat stress. Cell Stress Chaperones 2006 0.97
29 Up-regulated autophagy by endogenous high mobility group box-1 promotes chemoresistance in leukemia cells. Leuk Lymphoma 2011 0.95
30 RAGE regulates autophagy and apoptosis following oxidative injury. Autophagy 2011 0.93
31 Metabolic regulation by HMGB1-mediated autophagy and mitophagy. Autophagy 2011 0.92
32 Not just nuclear proteins: 'novel' autophagy cancer treatment targets - p53 and HMGB1. Curr Opin Investig Drugs 2008 0.89
33 Ménage à Trois in stress: DAMPs, redox and autophagy. Semin Cancer Biol 2013 0.89
34 Inhibiting autophagy potentiates the anticancer activity of IFN1@/IFNα in chronic myeloid leukemia cells. Autophagy 2012 0.89
35 Chloroquine inhibits HMGB1 inflammatory signaling and protects mice from lethal sepsis. Biochem Pharmacol 2013 0.88
36 microRNA 30A promotes autophagy in response to cancer therapy. Autophagy 2012 0.88
37 Damage associated molecular pattern molecule-induced microRNAs (DAMPmiRs) in human peripheral blood mononuclear cells. PLoS One 2012 0.87
38 Direct molecular interactions between HMGB1 and TP53 in colorectal cancer. Autophagy 2012 0.85
39 A critical role for UVRAG in apoptosis. Autophagy 2011 0.84
40 Sweating the small stuff: microRNAs and genetic changes define pancreatic cancer. Pancreas 2013 0.81
41 The chemokine receptors CXCR4/CXCR7 and their primary heterodimeric ligands CXCL12 and CXCL12/high mobility group box 1 in pancreatic cancer growth and development: finding flow. Pancreas 2015 0.79
42 HMGB1 is a therapeutic target for leukemia. Am J Blood Res 2012 0.78
43 Autophagy is required for IL-2-mediated fibroblast growth. Exp Cell Res 2012 0.77
44 Hsp27: a novel therapeutic target for pediatric M4/M5 acute myeloid leukemia. Oncol Rep 2013 0.76
45 Poly-ADP-ribosylation of HMGB1 regulates TNFSF10/TRAIL resistance through autophagy. Autophagy 2015 0.76
46 Hepatocyte-specific Hmgb1 Deletion. Autophagy 2015 0.75